By Adriano Marchese
Aurora Cannabis swung to a profit in its fiscal third-quarter thanks rise in the estimated value of its biological assets and strong medical cannabis revenue.
The Canadian cannabis company on Wednesday posted net income from continuing operations of 31.2 million Canadian dollars ($21.8 million) for the three months ended Dec. 31, compared with a loss of C$17.1 million in the prior-year period.
Aurora's profit includes an increase in unrealized gain on changes in fair value of biological assets of C$42.4 million, it said.
Adjusted earnings before interest, taxes, depreciation and amortization jumped to C$23.1 million from C$5.5 million.
Net revenues rose 37% to C$88.2 million, topping expectations of a rise to C$79.9 million, thanks to a 51% rise in medical cannabis and plant propagation revenue. Meanwhile, consumer cannabis net revenue continued its decline, falling 15%.
Looking ahead, Aurora expects continued revenue growth across its cannabis business, supported by strengthening international medical cannabis, while margins are expected support continued positive adjusted Ebitda.
Write to Adriano Marchese at adriano.marchese@wsj.com
(END) Dow Jones Newswires
February 05, 2025 07:26 ET (12:26 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。